Products You May Like
TORONTO, June 03, 2021 (GLOBE NEWSWIRE) — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare expertise and companies firm, immediately introduced a rebrand of the corporate to assist its evolution from funding insurer to health-tech disruptor. The brand new visible id additionally unites all belongings and subsidiaries below a single Medivolve model umbrella, additional cementing the corporate’s transfer towards a strong, singular mission to create more healthy lives. The brand new branding displays the long-term strategic imaginative and prescient of Medivolve’s newly appointed CEO, David Preiner, underscored by momentum from a collection of current acquisitions and company milestones.
“Medivolve’s rebranding is a lot greater than a brand new shade palette and brand – it is a chance for us to share our renewed imaginative and prescient for the enterprise, for physicians and sufferers, and the way forward for healthcare in America,” stated David Preiner, CEO of Medivolve. “As we proceed to develop, we’re bringing collectively the items to construct a SaaS-based health-tech platform that’s extra useful than the sum of its components, and our model should mirror this mannequin and method. I’m proud that now, as individuals all around the nation are handled at a Medivolve testing website, they’ll instantly determine with a model they’ll belief to always innovate and empower a continuity of care by no means seen earlier than.”
The corporate’s new visible id shall be represented on all of its cellular COVID-19, immunology and vaccination testing websites round america, the place Individuals can go for quick, correct, and accessible testing when and the place they want it. Efficient instantly, it can discontinue the identify “Collections Websites” and function all belongings below the Medivolve company identify and branding. The rebrand features a new web site, brand, shade palette, and refreshed social media channels. Medivolve’s shift to the colour pink is a purposeful model determination signifying Medivolve’s ardour and power for bettering the way forward for well being administration.
As a part of this rebrand, Medivolve has created an informative video highlighting its new id and evolution into an progressive healthcare supplier centered on remodeling human well being administration throughout america. Shifting ahead, Medivolve’s workforce of medical consultants will concentrate on bettering affected person care and rising collaboration with clinicians to supply a extra holistic healthcare answer and assist create more healthy lives.
The rebrand is one in all a number of vital initiatives launched below the corporate’s new management workforce. Up to now a number of weeks since David Preiner took the helm as CEO, Medivolve introduced it has expanded its portfolio of pharmacy acquisitions, with an settlement to amass Marbella Pharmacy, offering Medivolve rapid entry to pharmaceutical distribution all through the state of California. Medivolve additionally accomplished the acquisition of its Digital Well being Document expertise, which is able to function its cloud-based platform for bettering affected person care and rising collaboration with clinicians.
About Medivolve Inc.
Medivolve Inc. (NEO:MEDV; OTC:COPRF; FRA:4NC) focuses on discovering and growing disruptive applied sciences, ground-breaking improvements, and unique partnerships to assist fight COVID-19 and rework human well being administration. This contains offering handy and accessible medical companies for testing, prevention, and remedy. Medivolve is comprised of a workforce of famend world medical and enterprise advisors who’re dedicated to serving to fulfill Medivolve’s mission of looking for and investing in breakthrough sciences, applied sciences, analysis, or resolutions to empower the betterment of humankind. This panel contains distinguished Stanford neurologist and immunologist Dr. Lawrence Steinman and Dr. Glenn Copeland, one in all North America’s most distinguished orthopedic remedy and sports activities drugs specialists.
For investing inquiries, please contact:
For U.S. media inquiries, please contact:
Cautionary Be aware Relating to Ahead-looking Info
This press launch comprises “forward-looking info” inside the which means of relevant Canadian securities laws. Ahead-looking info contains, however is just not restricted to, statements with respect to the acquisition of the well being platform app; the advantages and alternatives associated to the well being platform app; the pursuit by Medivolve of alternatives; and the deserves or potential returns of any such alternatives. Usually, forward-looking info may be recognized by means of forward-looking terminology corresponding to “plans”, “expects” or “doesn’t anticipate”, “is predicted”, “funds”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “doesn’t anticipate”, or “believes”, or variations of such phrases and phrases or state that sure actions, occasions or outcomes “could”, “might”, “would”, “would possibly” or “shall be taken”, “happen” or “be achieved”. Ahead-looking info is topic to recognized and unknown dangers, uncertainties and different elements that will trigger the precise outcomes, stage of exercise, efficiency, or achievements of the Firm, because the case could also be, to be materially totally different from these expressed or implied by such forward-looking info. Though the Firm has tried to determine vital elements that might trigger precise outcomes to vary materially from these contained in forward-looking info, there could also be different elements that trigger outcomes to not be as anticipated, estimated or supposed. There may be no assurance that such info will show to be correct, as precise outcomes and future occasions might differ materially from these anticipated in such statements. Accordingly, readers mustn’t place undue reliance on forward-looking info. The Firm doesn’t undertake to replace any forward-looking info, besides in accordance with relevant securities legal guidelines.
NEITHER THE NEO EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.